Loading...
XSHG
600587
Market cap1.30bUSD
Dec 05, Last price  
15.15CNY
1D
0.73%
1Q
-7.51%
Jan 2017
-39.67%
IPO
192.47%
Name

Shinva Medical Instrument Co Ltd

Chart & Performance

D1W1MN
XSHG:600587 chart
P/E
13.29
P/S
0.92
EPS
1.14
Div Yield, %
4.29%
Shrs. gr., 5y
8.34%
Rev. gr., 5y
2.71%
Revenues
10.02b
+0.09%
415,249,469483,164,962528,908,872654,964,324885,836,6161,342,233,4082,106,132,0623,035,561,2254,193,764,3176,283,466,6697,554,444,2518,364,495,5309,983,246,17210,283,639,0288,766,761,0759,150,960,4109,482,198,7519,281,768,65710,011,868,42310,020,618,625
Net income
692m
+5.75%
15,104,97020,870,10922,433,86529,868,33841,286,79060,352,282107,257,530163,311,032231,680,197326,441,336280,833,88134,636,29065,528,72222,784,139861,314,742234,138,976556,493,783500,072,195653,997,275691,609,558
CFO
451m
-56.24%
058,141,917049,285,184106,291,491124,164,572010,867,02522,355,70052,058,790110,434,996188,745,622947,089,785653,215,493630,910,0801,098,102,3941,402,538,527388,048,5661,030,114,479450,733,485
Dividend
Jun 06, 20240.65 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Shinva Medical Instrument Co., Ltd. provides medical instruments and equipment in the People's Republic of China. It offers CSSD integrated solutions, pharmaceutical equipment integrated solutions, radiotherapy integrated solutions, digital operating room integrated solutions, dental integrated solutions, medical environmental protection integrated solutions, experiment animal safeguard integrated solutions, in vitro diagnostic reagents and instruments, and biomedical materials and supplies. The company also provides pharmaceutical machinery and air purifiers. Shinva Medical Instrument Co., Ltd. was founded in 1943 and is headquartered in Zibo, the People's Republic of China.
IPO date
Sep 27, 2002
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT